about
Toxoplasma gondii AP2IX-4 Regulates Gene Expression during Bradyzoite Development.Elp3 and RlmN: A tale of two mitochondrial tail-anchored radical SAM enzymes in Toxoplasma gondii.Characterization of Plasmodium Atg3-Atg8 interaction inhibitors identifies novel alternative mechanisms of action in Toxoplasma gondii.Transcriptional repression by ApiAP2 factors is central to chronic toxoplasmosis.Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondiiGuanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing NeuroinflammationSimultaneous Ribosome Profiling of Human Host Cells Infected with Toxoplasma gondii.Regulation of arginine transport by GCN2 eIF2 kinase is important for replication of the intracellular parasite Toxoplasma gondiiEfficacy of Guanabenz Combination Therapy Against Chronic Toxoplasmosis Across Multiple Mouse Strains
P50
Q37703340-F7651FE1-0491-460C-975D-C882BBAF1812Q47238965-66FA971B-259F-4290-88BC-8835BA93F803Q47381598-CE7FBF77-3A65-4816-9550-A7000BF99BB6Q52714731-808129E4-871C-4C0B-BC9D-9A7C2A8168C6Q57789685-4201B524-ACE0-4021-A53C-A480F25CDE4CQ64079805-4CCB7AE4-2557-445B-BD2D-4A685260D815Q64911764-CA53B159-8ED3-4105-95AF-36379567B9FCQ92719078-4E628E02-030F-4135-BEB3-06AA509D5B42Q96429381-0FAAD3C3-7BBF-4E70-AC60-4256CE662165
P50
description
researcher
@en
name
William J Sullivan
@en
type
label
William J Sullivan
@en
prefLabel
William J Sullivan
@en
P31
P496
0000-0003-1823-8642